Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity. — RECRUITING, PHASE2, PHASE3. Interventions: Semaglutide, Placebo. Locations: Montreal, Quebec, Canada. The goal of this 24 week double-blinded, randomized, parallel controlled clinical trial is to learn how semaglutide a...Source
Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes — RECRUITING, NA. Interventions: Tele-diabetes Remote System. Locations: Ramat Gan, Israel. The goal of this clinical trial is to examine the feasibility and effectiveness of a tele-diabetes remote monitoring system on ma...Source
The iLet Experience Study — RECRUITING. Interventions: iLet Dosing Decision Software. Locations: Irvine, California, United States. A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decisio...Source
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes — RECRUITING, NA. Interventions: MODI Algorithm. Locations: Baltimore, Maryland, United States | Detroit, Michigan, United States | Albany, New York, United States. A 13-week multi-center single-arm trial, preceded by a 2...Source
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes — RECRUITING, NA. Interventions: Moderate carbohydrate restriction, Early time-restricted eating, Standard calorie restriction. Locations: Málaga, Málaga, Spain. Although type 1 diabetes (T1D) has traditionally been consi...Source
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes — RECRUITING, PHASE4. Interventions: Montelukast, Placebo. Locations: Aurora, Colorado, United States. Kidney disease is a common problem among people with type 1 diabetes and can lead to disability, dialysis, and early d...Source
Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System — RECRUITING, NA. Interventions: Questionnar. Locations: Grenoble, France. The BF-ACT study is a single-center, non-interventional (RIPH3) descriptive study conducted at CHU Grenoble Alpes. It aims to evaluate the satisfa...Source
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus — RECRUITING, PHASE2. Interventions: OPT101, OPT101 Placebo to Match (PTM). Locations: Birmingham, Alabama, United States | Walnut Creek, California, United States | Aurora, Colorado, United States. This study will examin...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.